Phase 1 Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01155817
Recruitment Status : Unknown
Verified May 2013 by David Miklos, Stanford University.
Recruitment status was:  Active, not recruiting
First Posted : July 2, 2010
Last Update Posted : May 7, 2013
Information provided by (Responsible Party):
David Miklos, Stanford University